Japan Cataract Surgery Devices Market Trends 2026–2034

Japan Cataract Surgery Devices Market Size and Forecast 2026-2034

Japan Cataract Surgery Devices Market is expected to reach US$ 557.39 Million by 2034 from US$ 423.48 Million in 2025, with a CAGR of 3.1% from 2026 to 2034. Japan’s cataract surgery devices market is expanding due to rapid population aging, increasing cataract prevalence, growing demand for premium intraocular lenses (IOLs), rising adoption of minimally invasive surgical technologies, and continuous innovation in ophthalmic equipment that improves surgical precision, efficiency, and patient outcomes.

Japan Cataract Surgery Devices Industry Overview

Cataract surgery devices are specialized medical instruments and implants used to remove clouded natural lenses and restore vision in patients affected by cataracts. These devices include phacoemulsification systems, femtosecond laser platforms, ophthalmic viscoelastic devices, surgical microscopes, intraocular lenses (IOLs), and consumables used during surgery. Modern cataract procedures rely heavily on advanced technologies that improve accuracy, reduce recovery time, and enhance visual outcomes. Premium IOLs such as multifocal, trifocal, toric, and extended-depth-of-focus lenses are increasingly used to reduce dependence on glasses. Continuous technological advancements are making cataract surgery safer, faster, and more personalized for patients.

Japan represents one of the world's largest cataract surgery markets because of its rapidly aging population and high healthcare standards. The growing number of people aged 65 years and above increases the incidence of age-related cataracts, driving demand for surgical intervention and advanced ophthalmic devices. Rising patient awareness regarding premium vision correction options, including trifocal and extended-depth-of-focus intraocular lenses, further supports market growth. Technological innovations in surgical planning systems, digital visualization tools, and advanced IOL materials are improving surgical outcomes and encouraging adoption. Government-supported healthcare access and strong ophthalmology infrastructure also contribute to sustained market expansion.

Recent Developments in Japan Cataract Surgery Devices Market

• In March 2026, Japan Alcon announced the nationwide launch of Clareon® PanOptix® Pro, a next-generation trifocal intraocular lens for cataract patients. The lens was designed to improve light utilization efficiency, achieving approximately 94% light transmission while enhancing contrast sensitivity from distance to intermediate vision. The product expands premium vision-correction options for Japanese cataract patients seeking greater spectacle independence and improved postoperative visual quality.
• In April 2025, Alcon launched the UNITY® Cataract System (CS), a standalone cataract surgery platform incorporating UNITY 4D Phaco technology and Intelligent Fluidics. The company announced shipments to Japan beginning in 2025. The system is designed to improve surgical efficiency, reduce ultrasound energy delivered to the eye, and enhance chamber stability during cataract procedures. The launch represents one of the most significant surgical equipment introductions in the ophthalmology sector.

Growth Drivers for the Japan Cataract Surgery Devices Market

Aging Population Increasing Cataract Burden

Japan has one of the oldest populations globally, creating a substantial patient pool for cataract surgeries. Cataracts are strongly associated with aging, and the rising proportion of elderly individuals is increasing the number of patients requiring lens replacement procedures. According to population statistics, nearly 29.3% of Japan’s population was aged 65 years and above in 2024, highlighting a large demographic vulnerable to cataract development. As life expectancy increases, demand for cataract surgery continues to rise, supporting purchases of phacoemulsification systems, surgical consumables, and intraocular lenses. Hospitals and ophthalmology centers are expanding surgical capacity to meet this demand. The long-term demographic trend is expected to sustain growth for cataract surgery devices throughout the forecast period.

In April 2024, BVI Medical officially launched the PODEYE Hydrophobic Monofocal Intraocular Lens (IOL) in Japan following approval by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). The product was introduced at the Japanese Ophthalmological Society meeting in Tokyo and was specifically designed for the Japanese market, where hydrophobic IOLs dominate cataract procedures.

Rising Adoption of Premium Intraocular Lenses (IOLs)

Demand for premium cataract surgery outcomes is increasing across Japan as patients seek greater independence from spectacles after surgery. Multifocal, toric, and extended-depth-of-focus (EDOF) lenses are gaining acceptance because they improve vision at multiple distances while enhancing quality of life. Rising awareness among patients and ophthalmologists regarding premium vision correction options is encouraging adoption. This trend is boosting revenues for device manufacturers and promoting innovation in lens design, optical performance, and patient customization. Premium IOL adoption is expected to remain one of the fastest-growing segments within Japan’s cataract surgery devices market.

In May 2025, Johnson & Johnson Surgical Vision Japan announced that TECNIS PureSee OptiBlue and TECNIS PureSee Toric II OptiBlue—its next-generation non-diffractive extended-depth-of-focus (EDOF) intraocular lenses—would be launched in Japan in June 2025. The new lenses were developed to provide continuous high-quality vision across multiple distances while minimizing glare and halo effects, supporting the growing demand for premium cataract surgery outcomes among Japanese patients. The launch strengthens the availability of advanced presbyopia-correcting IOL technologies in Japan and reflects the increasing adoption of premium vision correction solutions in cataract care.

Technological Innovation and Advanced Surgical Platforms

Japan’s ophthalmology sector is rapidly adopting advanced surgical technologies that improve precision, efficiency, and patient outcomes. Digital planning systems, advanced fluidics, image-guided surgery, and integrated surgical platforms are enabling more predictable cataract procedures. Hospitals and eye clinics increasingly invest in next-generation equipment to improve workflow efficiency and support growing surgical volumes. Manufacturers continue to introduce innovative solutions that reduce procedure times and enhance surgeon control, creating strong growth opportunities across the cataract surgery ecosystem.

NIDEK, headquartered in Japan, launched the NexRoad NP-T Preloaded Toric IOL System in February 2024. The device combines a toric intraocular lens and injector system, offering improved rotational stability and streamlined implantation during cataract surgery.

Challenges in the Japan Cataract Surgery Devices Market

High Cost of Premium Cataract Technologies

Although Japan has a well-developed healthcare system, the adoption of premium cataract surgery technologies can be limited by their higher costs. Advanced trifocal, toric, and extended-depth-of-focus intraocular lenses often require additional patient expenditure beyond standard treatment coverage. Similarly, investments in digital surgical platforms, femtosecond laser systems, and advanced visualization equipment place financial pressure on healthcare facilities. Smaller clinics may face budget constraints when upgrading existing infrastructure. Cost concerns can reduce adoption rates among price-sensitive patients and healthcare providers, limiting penetration of premium technologies. Manufacturers must balance innovation with affordability while demonstrating long-term clinical and economic benefits to encourage broader acceptance across hospitals and ophthalmology centers.

Shortage of Specialized Ophthalmic Workforce

The growing volume of cataract procedures is increasing demand for skilled ophthalmic surgeons and trained operating-room staff. Advanced cataract technologies require specialized training and experience to maximize clinical outcomes. In some regions, workforce shortages and uneven distribution of specialists can create surgical backlogs and longer waiting times. Adoption of sophisticated surgical systems may also require continuous professional education and technical support. Healthcare facilities must invest in training programs to ensure efficient utilization of new devices. As Japan’s elderly population continues to expand, maintaining sufficient numbers of qualified ophthalmologists and support staff will remain a critical challenge for sustaining market growth and ensuring timely access to cataract treatment.

Tokyo Cataract Surgery Devices Market

Tokyo represents the largest cataract surgery devices market in Japan due to its extensive healthcare infrastructure, concentration of tertiary hospitals, and high patient awareness regarding advanced ophthalmic treatments. The region experiences strong demand for premium intraocular lenses, image-guided surgery systems, and digital surgical planning platforms. Large academic medical centers frequently adopt innovative technologies earlier than other regions, creating favorable opportunities for device manufacturers.

Tokyo also benefits from high healthcare expenditure and access to specialized ophthalmologists. Demand is further supported by a large elderly population requiring cataract intervention. According to Tokyo Metropolitan Government estimates, the number of residents aged 65 years and above reached approximately 3.12 million, demonstrating a substantial target patient population for cataract surgery services.

Osaka Cataract Surgery Devices Market

Osaka is a major healthcare and medical technology hub in western Japan and contributes significantly to national cataract surgery volumes. The prefecture has a mature hospital network and a high concentration of ophthalmology clinics performing cataract procedures. Growing adoption of premium IOLs and advanced surgical equipment is enhancing market prospects. Healthcare providers increasingly focus on improving visual outcomes and patient satisfaction, encouraging investment in innovative cataract technologies.

The region’s aging demographics further support procedure growth. Population estimates indicate that 27.6% of Osaka’s population was aged 65 years or older in 2024, reflecting one of the largest elderly patient pools in the country. This demographic profile creates sustained demand for cataract surgery devices and related ophthalmic technologies.

Aichi Cataract Surgery Devices Market

Aichi is an important medical and industrial prefecture with a strong healthcare infrastructure and significant purchasing power. The presence of advanced hospitals and research-oriented healthcare institutions supports adoption of innovative ophthalmic technologies. Cataract surgery demand is increasing as the population ages and awareness of premium vision correction solutions expands. The region also benefits from strong economic activity, enabling healthcare facilities to invest in technologically advanced surgical equipment and digital ophthalmology platforms. Aichi’s healthcare providers increasingly focus on enhancing surgical efficiency and postoperative visual quality. According to official population estimates, Aichi had approximately 7.46 million residents in 2024, making it one of Japan’s largest prefectures and a substantial market for cataract surgery devices and ophthalmic consumables.

Kanagawa Cataract Surgery Devices Market

Kanagawa is one of Japan’s largest prefectural healthcare markets and benefits from its proximity to Tokyo. The region hosts numerous hospitals, specialty eye clinics, and advanced surgical centers that actively adopt modern cataract technologies. Growing elderly populations and increasing patient expectations regarding spectacle independence are driving demand for premium IOLs and precision surgical devices. Healthcare providers are investing in advanced diagnostic and surgical planning systems to improve clinical outcomes and operational efficiency. The prefecture also maintains strong healthcare accessibility across urban centers such as Yokohama. According to population estimates, Kanagawa had approximately 2.4 million residents aged 65 years and above in 2024, representing a significant cataract patient base and supporting long-term demand for cataract surgery devices.

Japan Intraocular Lens (IOL) Market

The intraocular lens (IOL) segment represents the largest revenue-generating category within Japan’s cataract surgery devices market. Demand is increasing due to the growing number of cataract surgeries, rising life expectancy, and patient preference for improved postoperative visual outcomes. Japanese ophthalmologists are increasingly adopting premium IOLs, including multifocal, toric, trifocal, and extended-depth-of-focus (EDOF) lenses, which provide greater spectacle independence. Continuous product innovation from manufacturers such as Alcon, Johnson & Johnson Vision, HOYA, and NIDEK is further supporting market expansion. The introduction of advanced hydrophobic acrylic materials and preloaded delivery systems is enhancing surgical efficiency and patient satisfaction. As awareness of premium vision correction grows, the IOL market is expected to remain a key growth contributor to Japan’s cataract surgery devices industry.

Japan Hospitals Market

Hospitals constitute a major end-user segment within Japan’s cataract surgery devices market, accounting for a significant share of advanced cataract procedures performed nationwide. Large public and private hospitals are increasingly investing in state-of-the-art phacoemulsification systems, ophthalmic microscopes, digital surgical guidance platforms, and premium intraocular lens technologies to improve surgical outcomes. Hospitals benefit from the availability of specialized ophthalmology departments, experienced surgeons, and access to advanced diagnostic equipment. The growing elderly population and increasing cataract surgery volumes are encouraging healthcare facilities to expand ophthalmic services and upgrade surgical infrastructure. Furthermore, hospitals are often early adopters of newly approved cataract technologies, making them a critical channel for market growth. Their role in managing complex cataract cases further strengthens demand for advanced surgical devices.

Japan Cataract Surgery Devices Market Segmentation:

Product Type

• Intraocular Lens
• Phacoemulsification Systems
• Femtosecond Laser
• Ophthalmic Viscoelastic Devices and Other Consumables

End Use

• Hospitals
• Ophthalmic Clinics
• Research Institutes

Cities

• Tokyo
• Kansai
• Aichi
• Kanagawa
• Saitama
• Hyogo
• Chiba
• Hokkaido
• Fukuoka
• Shizuoka

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Alcon, Inc.
• Johnson & Johnson
• Carl Zeiss Meditec AG
• Bausch & Lomb, Inc.
• Topcon Corp
• STAAR Surgical Co
• Glaukos Corp
• Abbott Laboratories

Report Details: